US pharma giant Pfizer (NYSE: PFE) today announced that after a comprehensive internal and external selection process, the ...

Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA).

California, USA-based biotech Cytokinetics saw its shares fall as much as 4% to $9.67 yesterday, after it announced a deal ...

The landscape of atopic dermatitis (AD) treatment is advancing with approvals of oral and topical Janus kinase (JAK) ...

Samsung Biologics has secured a $668 million manufacturing agreement with a European pharma, bringing its total deals for the ...

Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). A ...

Johnson & Johnson and Protagonist Therapeutics announced positive Phase III results for icotrokinra, an oral IL-23 targeting ...

The UK’s health technology assessor the Institute for Health and Clinical Excellence (NICE) says that talks with the makers ...

US pharma giant Merck & Co (NYSE: MRK) today announced positive top-line results from the pivotal Phase III MK-3475A-D77 ...

The company is confident that it is on to something special with its novel anti-growth differentiation factor-15 (GDF-15) ...

Aclaris Therapeutics has entered an exclusive licensing deal with Biosion for two antibodies, BSI-045B for atopic dermatitis ...

New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, ...